Jangwoo Shin

Senior Principal Scientist @ Yuhan Corporation

About

Biopharma leader with 25+ years of experience in drug discovery, R&D strategy, portfolio management, and global business development.Experienced across oncology, immunology, liver diseases, natural products, and biologics at Yuhan Corporation.Led pipeline evaluations, licensing reviews, and strategic project development including two years in Boston, U.S.Focused on connecting science with business growth and pipeline value.Open to leadership opportunities in R&D Strategy, Licensing, Portfolio Management, and Global BD

Country

South Korea

City

Yongin

Industry

Pharmaceuticals

Skill

Evaluation of drug candidates, Immuno-oncology drug development, herbal medicine development

Experience

Senior Principal Scientist

Yuhan Corporation

2025-7 - Present · 1 yr 3 mos

Yongin-si Gyeonggi-do

• Lead strategic R&D initiatives • Support portfolio and pipeline decisions • Evaluate innovation opportunities • Collaborate across research and business

Senior Principal Scientist

Yuhan USA

2023-7 - 2025-6 · 2 yrs

미국 매사추세츠 보스턴

Conducted technical review of biotech assets for potential partnering and in-licensing opportunities. Proposed in-licensing opportunities to headquarters based on scientific and market assessments.

Senior Principal Scientist

Yuhan Corporation

2010-12 - 2023-6 · 12 yrs 7 mos

Yongin-si Gyeonggi-do

Conducted in vivo efficacy evaluations for natural and synthetic drugs, as well as biopharmaceuticals. Led projects in oncology and immune-related diseases. Reviewed external candidates and proposed in-licensing to strengthen the pipeline

Research Professor

Daejeon University

2001-1 - 2010-11 · 9 yrs 11 mos

Daejeon Korea

Managed projects from conception to completion. Prepared and submitted Investigational New Drug (IND) applications for herbal medicine products to regulatory authorities. Designed and executed preclinical efficacy studies in cancer and liver disease models (in vitro and in vivo). Responsible for the strategic oversight and data interpretation of outsourced GLP toxicology programs.